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422Objective: The preoperative ejection fraction (EF) and left ventricular (LV) end-systolic dimension are known
predictors of postoperative LV dysfunction after mitral valve repair. We investigated the effect of a preoperative
history of atrial fibrillation and moderate pulmonary hypertension (defined as pulmonary artery systolic pressure
>50 mm Hg) on early postoperative LV dysfunction.
Methods: From 2003 to 2010, 632 patients who had undergone successful mitral valve repair surgery for
degenerative disease were included in the present study. The preoperative and postoperative echocardiographic
data and postoperative outcomes were collected retrospectively. We analyzed the demographic, hemodynamic,
and echocardiographic parameters to assess the predictors of early postoperative LV dysfunction, defined as an
LVEF<50%.
Results: The mean age of the cohort was 57  13 years. All patients had less than mild mitral regurgitation
on postoperative echocardiography. After mitral valve repair, a significant decrease in the LVEF (60%  8%
to 54%  9%), LV end-systolic diameter (36  7 mm to 33  7 mm), and LV end-diastolic dimension
(56  8 mm to 48  7 mm) was observed at early postoperative echocardiography (P<.001). On multivariate
regression analysis, preoperative atrial fibrillation, pulmonary hypertension, and LV end-systolic dimension
were independent predictors of the postoperative LVEF (P¼ .035 and P<.001, respectively). Preoperative atrial
fibrillation (odds ratio, 1.97; 95% confidence interval, 1.28-3.02; P ¼ .002) and pulmonary artery systolic
pressure>50 mm Hg (odds ratio, 1.82; 95% confidence interval, 1.11-2.97; P ¼ .017) increased the risk of
postoperative LV dysfunction by almost twofold.
Conclusions: In addition to the established predictors of postoperative LV dysfunction, the presence of
preoperative pulmonary hypertension and a history of atrial fibrillation in patients undergoingmitral valve repair
surgery increased the risk of early postoperative LV dysfunction by almost twofold. (J Thorac Cardiovasc Surg
2014;148:422-7)Mitral valve repair is the recommended treatment for
patients with severe degenerative mitral valve disease.
Despite having a preoperative preserved ejection fraction
(EF), a number of patients will develop early left ventricular
(LV) dysfunction after valve reconstruction. A number of
studies have examined the echocardiographic predictors
of LV dysfunction after valve replacement.1 However,
some have examined this question in a mixed cohort of
valve repair and valve replacement,2,3 and others have
examined a mixed cohort of mitral valve diseasee Department of Cardiothoracic Surgery, Icahn School of Medicine, Mount
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The Journal of Thoracic and Cardiovascular Surg(degenerative, ischemic, and rheumatic).4 None have
thoroughly examined the nonechocardiographic predictors
of early postoperative LV dysfunction. Furthermore,
whether early postoperative LV dysfunction after mitral
valve reconstruction affects morbidity and mortality has
not been examined.
In the present large series, we sought to examine the
echocardiographic and nonechocardiographic predictors
of early postoperative LV dysfunction after mitral valve
repair for degenerative valve disease and its effects on
surgical outcomes.METHODS
Study Population
From June 2003 to December 2010, we retrospectively analyzed the
data from 646 consecutive patients who underwent mitral valve surgery
for degenerative mitral valve regurgitation by a single surgical team.
Patients were excluded from the present study if they had undergone
mitral valve replacement (1 patient) or had not undergone a complete
predischarge echocardiogram (13 patients). Patients with concomitant
tricuspid valve repair or coronary artery bypass grafting for incidental
coronary disease found during preoperative catheterization were includedery c August 2014
Abbreviations and Acronyms
AF ¼ atrial fibrillation
EF ¼ ejection fraction
LV ¼ left ventricular
LVEF ¼ left ventricular ejection fraction
PHT ¼ pulmonary hypertension
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present analysis.
The Mount Sinai School of Medicine institutional review board
approved the present research protocol.
The patients underwent a variety of techniques in repairing the mitral
valve using a lesion-specific approach, as described previously.5,6 These
techniques included quadrangular or triangular resection, leaflet sliding
plasty, neochordal replacement, and commissuroplasty. Most patients
received a complete annuloplasty ring; a small percentage received an
incomplete annuloplasty ring. Tricuspid valve repair was undertaken if
more than mild regurgitation or annular dilatation was present. Complete
left sided or biatrial ablation was undertaken for all patients in persistent
or permanent atrial fibrillation (AF).
During valve repair, myocardial protection was maintained using an
induction dose of antegrade blood cardioplegia, with maintenance
cardioplegia given mostly in a retrograde manner by way of a catheter in
the coronary sinus. Cold blood cardioplegia was administered at 4C and
consisted of a 4:1 ratio of blood to cardioplegia. The doses were
administered approximately every 20 to 25 minutes. Before removal of
the crossclamp, a dose of warm blood was administered through the
retrograde catheter.Echocardiographic Parameters
All patients had a preoperative transthoracic echocardiogram
documenting severe mitral valve regurgitation. The degree of regurgitation
was measured using a variety of techniques according to the guidelines of
the American Society of Echocardiography. If doubt was present regarding
the degree of mitral valve regurgitation on an echocardiogram from an
outside institution, the echocardiogram was repeated at our hospital using
proximal isovelocity surface area (effective regurgitant orifice area, effec-
tive regurgitant volume) and qualitative measurements such as reversal of
flow in the pulmonary veins to assess mitral regurgitation. Transthoracic
echocardiograms were performed in all patients after valve repair and
before discharge from the hospital. The mean interval to echocardiography
was 4.1 days. PostoperativeLVdysfunctionwas defined as anLVEF<50%.
Other echocardiographic parameters such as the LV end-systolic diameter
(LVESD), LV end-diastolic diameter (LVEDD), and left atrial diameter
were also measured using the American Society of Echocardiography
guidelines. Preoperative pulmonary artery systolic pressures were obtained
from preoperative catheterization if available and, if not, by echocardio-
graphy using the simplified Bernoulli’s equation [pulmonary artery systolic
pressure ¼ 4 3 (peak tricuspid regurgitant velocity)2 þ mean right atrial
pressure]. Pulmonary hypertension (PHT) was defined using the American
HeartAssociation/AmericanCollege ofCardiology guideline of 50mmHg.
AF was defined as permanent, persistent, and paroxysmal AF. All patients
with permanent or persistent AF underwent ablation. All but 1 patient
with paroxysmalAFunderwent ablation.That patient had a historyof 1 brief
episode of paroxysmal AF and did not undergo ablation.
Statistical Analysis
Continuous variables are presented as the mean standard deviation, if
normally distributed, and the median and interquartile range, if not
normally distributed. Categorical variables are presented as proportionsThe Journal of Thoracic and Caand absolute numbers. For continuous variables, the normality test was
performed using the combination of the Kolmogorov-Smirnov test and a
visual assessment of the histograms. The differences between the 2 groups
were detected using the chi-square test or Fisher’s exact test for categorical
variables and unpaired and paired Student t tests or the Mann-Whitney
U test for continuous variables. Logistic and linear regression analyses
were performed to identify the univariate and multivariate predictors of
postoperative LV dysfunction and LVEF, respectively. Variables with
P< .25 on univariate analysis were included in the final multivariate
model. In logistic regression analysis, the model fit and predictive power
were validated using the Hosmer-Lemeshow goodness-of-fit test and
c-statistic. Before multivariate analysis, a correlation analysis between
each variable was performed (Pearson or Spearman, as appropriate)
to ensure no violation of the assumption of multicollinearity (cutoff
correlation coefficient< 0.7). The results are presented as odds ratios,
with the corresponding 95% confidence intervals. P<.05 was considered
statistically significant. All P values are the results of 2-tailed tests. The
statistical analysis was performed using IBM SPSS Statistics for Windows,
version 20.0 (SPSS, Inc, IBM Corp, Armonk, NY).
RESULTS
The baseline characteristics of the patients are listed in
Table 1. Of the 646 patients, 242 (38.3%) developed
postoperative LV dysfunction. We observed that 68% of
the patients in the series had a preoperative LVEF>60%
and 85.3% of patients had a preoperative LVEF> 50%.
On average, the patients who developed LV dysfunction
were 2.7 years older. More than one half of the patients
(57.9%) in the series were symptomatic. The preoperative
comorbidities were otherwise similar in both groups. The
mean preoperative LVEF was slightly lower in the patients
who developed postoperative LV dysfunction compared
with those who did not (59.3% vs 61.5%). The patients
who developed postoperative LV dysfunction were more
likely to have a dilated ventricle, PHT, and AF. The etiology
of the degenerative disease was not different, and the
repair techniques used were similar in both groups
(Table 2). Barlow’s disease was evident in 339 patients
(53.6%), and posterior leaflet prolapse was the most
common lesion noted (475 patients; 75.2%). Tricuspid
annuloplasty was undertaken in 413 patients (65.3%).
The mean cardiopulmonary bypass times and crossclamp
times were not significantly different between the 2 groups
(Table 2).
Figure 1 illustrates the preoperative and postoperative
cardiac chamber sizes in the entire series. The mean
postoperative LVEF changed in the entire cohort by a
mean of 7.3%  10.8%. After valve repair, a significant
decrease was seen in the LVESD, LVEDD, and left atrial
diameter.
Tables 3 and 4 list the independent predictors of
postoperative LV dysfunction after mitral valve repair,
including LVESD, preoperative AF, and preoperative
PHT. The preoperative LVEF showed a trend toward
predicting postoperative LV dysfunction but the difference
was not statistically significant. We observed that in
patients with a preoperative LVEF of <60%, 34.2%rdiovascular Surgery c Volume 148, Number 2 423
TABLE 1. Baseline demographic data
Variable All patients (n ¼ 632)
Postoperative LV dysfunction
No (n ¼ 390) Yes (n ¼ 242) P value
Demographics and comorbidity
Age (y) 57.0  13.2 56.0  13.1 58.7  8.1 <.001
Female gender 229 (36.2) 148 (37.9) 81 (33.5) .255
Body surface area (m2) 1.90  0.25 1.89  0.24 1.92  0.25 .193
Hypertension 290 (45.9) 179 (45.9) 111 (45.9) .994
Hypercholesterolemia 163 (25.8) 105 (26.9) 58 (24.0) .409
Diabetes mellitus 20 (3.2) 8 (2.1) 12 (5.0) .042
Coronary artery disease 74 (11.7) 38 (9.7) 36 (14.9) .051
Obstructive lung disease 19 (2.9) 1 (0.8) 4 (2.9) .234
Peripheral vascular disease 7 (1.1) 6 (1.5) 1 (0.4) .288
Renal failure 2 (0.3) 2 (0.5) 0 (0) .260
Cerebrovascular accident 14 (2.2) 6 (1.8) 8 (3.3) .225
Symptomatic 366 (57.9) 228 (58.5) 138 (57.0) .722
Preoperative echocardiographic parameters
LVEF (%) 60.7  7.5 61.5  6.7 59.3  8.4 <.001
LVEF<50% 65 (10.3) 28 (7.2) 37 (15.3) .001
LVESD (mm) 35.8  6.8 34.6  6.2 37.8  7.3 <.001
LVESD>40 mm 159 (25.2) 74 (19.0) 85 (35.1) <.001
PA systolic pressure (mm Hg) 34.6  13.3 32.3  11.6 38.0  14.5 <.001
LVEDD (mm) 56.0  7.9 54.9  7.4 58.0  8.1 <.001
PASP>50 mm Hg 82 (13.0) 39 (10.0) 43 (17.8) .005
AF 124 (19.6) 58 (14.9) 66 (27.3) <.001
Data presented as mean standard deviation or n (%). LV, Left ventricular; LVEF, left ventricular ejection fraction; LVESD, left ventricular end-systolic diameter; PA, pulmonary
artery; LVEDD, left ventricular end-diastolic diameter; PASP, pulmonary artery systolic pressure; AF, atrial fibrillation.
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preoperative LVEF was<60%, the LVESD was>40 mm,
and AF and PHT were present, the incidence of
postoperative LV dysfunction increased to 66.7% (Table 5).
We examined the mortality and morbidity between the 2
groups (Table 6). One patient in the entire series died
(0.2%) but that patient had not developed postoperative
LV dysfunction. When comparing major postoperative
morbidity, we found no significant differences between
the 2 groups. The incidence of major morbidity and/or
mortality was 5.7%. Respiratory failure, defined as
mechanical ventilation for >48 hours (for any reason),
occurred in 4% of patients without LV dysfunction andTABLE 2. Operative data
Variable All patients (n ¼ 632)
Crossclamp time (min) 131  48
Cardiopulmonary bypass time (min) 167  77
Barlow’s disease 339 (53.6)
Anterior leaflet prolapse 27 (4.3)
Posterior leaflet prolapse 475 (75.2)
Bileaflet prolapse 123 (19.5)
Concomitant CABG 58 (9.2)
Concomitant TVR 413 (65.3)
Concomitant maze procedure 123 (19.5)
Data presented as mean  standard deviation or n (%). LV, Left ventricular; CABG, coron
424 The Journal of Thoracic and Cardiovascular Surg3.6% of patients with LV dysfunction (P¼ .549). The cause
in most of these cases was related to postoperative right
ventricular dysfunction in those with longer crossclamp
times, and the patients required inotropic support for the
right ventricle.
DISCUSSION
Postoperative LV dysfunction after mitral valve surgery
has been shown to occur in a number of studies.2,7
Similar to these series, the incidence of postoperative LV
dysfunction after mitral valve repair in our series was
significant, despite 85.3% of our patients having a
preoperative LVEF of >50%. Understanding thePostoperative LV dysfunction
No (n ¼ 390) Yes (n ¼ 242) P value
132  46 130  52 .848
162  51 176  111 .269
206 (52.8) 133 (55.0) .600
18 (4.6) 9 (3.7) .588
289 (74.1) 186 (76.9) .436
78 (20.0) 45 (18.6) .665
30 (7.7) 28 (11.6) .101
249 (63.8) 164 (67.8) .314
58 (14.9) 65 (26.9) <.001
ary artery bypass grafting; TVR, tricuspid valve repair.
ery c August 2014
FIGURE 1. The preoperative and postoperative cardiac chamber sizes for all patients. LVESD, Left ventricular end-systolic diameter; LVEDD, left
ventricular end-diastolic diameter; MVR, mitral valve repair.
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treatment of patients with degenerative mitral valve
disease. In our study, the LVESD and the presence of
PHT and AF independently predicted postoperative LV
dysfunction (LVEF< 50%). In a series of 861 patients,
Suri and colleagues2 examined the predictors of LV
dysfunction after mitral valve surgery and also found that
increased LV size, worsening heart failure symptoms,
preoperative LVEF, and AF predicted postoperative LV
dysfunction. Their series consisted of a mixed population
of patients undergoing either valve repair or replacement.
Tribouilloy and colleagues7 examined the predictors of
LV dysfunction at 10.8 months after mitral valve repair.
At 10 months after surgery, they continued to find a
decrease in the mean LVEF of 9%. The largest incidence
of postoperative LV dysfunction (33%) was found in
those patients with a preoperative LVEF < 64% and
LVESD  37 mm. Our study is unique in that it examined
early postoperative LV dysfunction (mean, 4.1 days) in
patients who had only undergone mitral valve repair for
degenerative disease.TABLE 3. Predictors of postoperative left ventricular ejection
fraction (continuous variables)
Variable
Univariate Multivariate
b P value b P value
Age (y) 0.092 .021 — .793
LVEF (%) 0.209 <.001 0.076 .057
ESD (mm) 0.337 <.001 0.299 <.001
PASP (mm Hg) 0.205 <.001 0.167 <.001
Left atrial diameter (mm) 0.185 <.001 — .407*
Crossclamp time (min) 0.006 .652 — —
LVEF, Left ventricular ejection fraction; ESD, end-systolic diameter; PASP,
pulmonary artery systolic pressure. *Multivariate analysis using left atrial diameter
was performed separately because of a larger number of missing cases.
The Journal of Thoracic and CaOur study did not find that the preoperative LVEF
predicted postoperative LV dysfunction, in contrast to
previous published studies. On multivariate analysis, the
P value for this measurement was .057. Although it showed
a trend toward significance, the preoperative LVEFs were
very similar in both groups and, hence, led to a type 1 error
in our study, because we did not have a sufficient sample
size to elicit a difference between the 2 groups.
We observed an overall decrease in the LVEF of
7.2% postoperatively. A number of explanations exist for
this decrease in the postoperative LVEF. Starling and
colleagues8 illustrated that the LVEF in the presence of
mitral regurgitation is overestimated as a result of the
increased ventricular preload (end-diastolic volume). After
valve repair, this excess preload is removed, leading to a
decrease in the end-diastolic volume and, subsequently, a
decrease in the LVEF. They showed that the contractile
reserve is a better indicator of LV function in the presence
of severe mitral regurgitation. Their work has beenTABLE 4. Predictors of postoperative left ventricular dysfunction
(categorical variables)
Variable
Univariate Multivariate
OR (95% CI)
P
value OR (95% CI)
P
value
Age (y) 1.02 (1.00-1.03) .014 .667
Female gender 0.82 (0.59-1.15) .255 —
Symptomatic 0.94 (0.68-1.30) .722 —
History of AF 2.49 (1.66-3.75) <.001 1.97 (1.28-3.02) .002
PASP>50 mm Hg 1.95 (1.22-3.10) .005 1.82 (1.11-2.97) .017
Concomitant CABG 1.57 (0.91-2.70) .103 .176
Concomitant TVR 1.19 (0.85-1.67) .314 —
In the final model, Hosmer-Lemeshow ¼ 0.814; c-statistic ¼ 0.680. OR, Odds ratio;
CI, confidence interval; AF, atrial fibrillation; PASP, pulmonary artery systolic
pressure; CABG, coronary artery bypass grafting; TVR, tricuspid valve repair.
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TABLE 5. Prevalence of postoperative LV dysfunction according to
presence of preoperative guideline parameters
Preoperative guideline parameters
Postoperative LV
dysfunction (n)
LVEF<60% only 26/76 (34.2)
LVEF<60% þ ESD>40 mm 26/54 (48.1)
LVEF<60% þ ESD>40 mm þ AF or PHT 17/24 (70.8)
LVEF<60% þ ESD>40 mm þ AF þ PHT 4/6 (66.7)
Data in parentheses are percentages. P ¼ .010 for all. LV, Left ventricular;
LVEF, left ventricular ejection fraction; ESD, end-systolic diameter; AF, atrial
fibrillation; PHT, pulmonary hypertension.
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Dsupported bymore recent evidence that measurements other
than the LVEF, such global strain and speckle tracking, can
better assess ventricular function when severe mitral
regurgitation is present.9,10 Other arguments for the early
decrease in the LVEF could be the increased afterload in
the ventricle after valve repair and the stress and/or
myocardial injury that occurs after aortic crossclamping.
A recent study found a similar decrease in the LVEF, in
addition to global longitudinal and circumferential strain,
on early postoperative echocardiograms at 7 days.11
Our finding that preoperative PHT increased the
incidence of postoperative LV dysfunction was likely a
result of the severity and duration of mitral regurgitation.
Enriquez-Sarano and colleagues12 elegantly reported
that as the severity of mitral regurgitation increased, a
corresponding increase occurred in the pulmonary artery
pressures. PHT also increased the incidence of right
ventricular dysfunction and could subsequently lead to a
decrease in LV preload and LVEF. In a recent multicenter
registry, patients with PHT had an increased risk of
operative mortality (hazard ratio, 2.15; P¼ .01) after mitral
valve surgery.13 Furthermore, long-term survival was also
diminished in the same study.
Just as with PHT, AF is a marker of the severity of
regurgitation and portends a worse prognosis in patientsTABLE 6. Perioperative mortality and morbidity
Variable
All patients
(n ¼ 632)
Postoperative LV dysfunction
No
(n ¼ 390)
Yes
(n ¼ 242)
P
value
30-d Mortality 1 (0.2) 1 (0.3) 0 (0) 1.000
Mortality and morbidity 36 (5.7) 22 (5.6) 14 (5.8) .939
Stroke 9 (1.4) 6 (1.5) 3 (1.2) .758
Myocardial infarction 0 0 0
Sternal wound infection 5 (0.8) 4 (1.0) 1 (0.4) .654
Bleeding 4 (0.6) 1 (0.3) 3 (1.2) .159
Sepsis 7 (1.1) 2 (0.5) 5 (2.1) .113
Gastrointestinal bleeding 1 (0.2) 1 (0.3) 0 (0) 1.000
Renal failure 3 (0.5) 2 (0.5) 1 (0.4) 1.000
Respiratory failure 25 (4.0) 14 (3.6) 11 (4.5) .549
Reoperation 5 (0.8) 3 (0.8) 2 (0.8) 1.000
Data presented as n (%). LV, Left ventricular.
426 The Journal of Thoracic and Cardiovascular Surgwith severe mitral regurgitation.14 AF has also been shown
to predict late survival after mitral valve repair.15 The
greatest incidence of postoperative LV dysfunction was
seen when patients presented with a combination of
LV dysfunction, increased ventricular dimensions, PHT,
and AF.
Postoperative LV dysfunction did not affect mortality or
morbidity after valve repair. We believe this was because
our threshold for defining LV dysfunction was 50%, and
most patients who developed LV dysfunction still had a
postoperative mean LVEF just<50%. One could postulate
that if the threshold definition of LV dysfunction was moved
toward 35% to 40%, a greater incidence of postoperative
complications would likely be seen, given the potential
for a longer intensive care unit and hospital stay; however,
this was not examined in our study.
In the present study, the presence of symptoms did not
increase the incidence of postoperative LV dysfunction.
However, given the finding of a twofold increase in
the risk of postoperative dysfunction in patients with
preoperative AF or PHT, these results support close
follow-up with a low threshold for surgical intervention
for patients with severe degenerative mitral valve disease.
We also believe that, in expert centers, early surgery in
asymptomatic patients should be considered where
mortality and morbidity remain low.
The strengths of the present study were the large sample
size and a homogenous population of patients with only
degenerative mitral valve disease. In addition, all patients
in the present series underwent valve repair. The limitations
of our study were its retrospective data collection. The
preoperative echocardiograms were frequently performed
at outside institutions; thus, an operator bias exists in the
interpretation of the echocardiograms. Finally, the lasting
implications of early postoperative ventricular dysfunction
were not examined.
CONCLUSIONS
Early postoperative LV dysfunction occurs commonly
after mitral valve repair for degenerative disease. The
independent predictors of postoperative LV dysfunction
were a large LV chamber size, PHT, and AF. Although no
increase in perioperative mortality or morbidity was
observed, patients who present with preoperative AF or
PHT had a twofold increase risk of developing post-
operative LV dysfunction.
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